# Frontier Group Holdings, Inc.: financial statements, quarterly

ULCC · Nasdaq · CIK 1670076 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ulcc.md) · [Financials](/companies/ulcc/financials.md) · [Filings](/companies/ulcc/filings.md) · [Insiders](/companies/ulcc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ulcc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [967](/filings/0001670076-24-000123.md) | [883](/filings/0001670076-24-000155.md) | [891 d](/filings/0001670076-26-000020.md) | [865](/filings/0001670076-25-000111.md) | [973](/filings/0001670076-25-000152.md) | [935](/filings/0001670076-25-000155.md) | [1,002 d](/filings/0001670076-26-000020.md) | [912](/filings/0001670076-26-000051.md) | [929](/filings/0001670076-25-000152.md) | [886](/filings/0001670076-25-000155.md) | [997 d](/filings/0001670076-26-000020.md) | [992](/filings/0001670076-26-000051.md) |
| Operating income | $m | [79.0](/filings/0001670076-24-000123.md) | [(54.0)](/filings/0001670076-24-000155.md) | [(3.0) d](/filings/0001670076-26-000020.md) | [(31.0)](/filings/0001670076-25-000111.md) | [25.0](/filings/0001670076-25-000152.md) | [19.0](/filings/0001670076-25-000155.md) | [45.0 d](/filings/0001670076-26-000020.md) | [(46.0)](/filings/0001670076-26-000051.md) | [(75.0)](/filings/0001670076-25-000152.md) | [(77.0)](/filings/0001670076-25-000155.md) | [49.0 d](/filings/0001670076-26-000020.md) | [(283)](/filings/0001670076-26-000051.md) |
| Interest expense | $m | [7.0](/filings/0001670076-24-000123.md) | [8.0](/filings/0001670076-24-000155.md) | [8.0 d](/filings/0001670076-26-000020.md) | [9.0](/filings/0001670076-25-000111.md) | [8.0](/filings/0001670076-25-000152.md) | [10.0](/filings/0001670076-25-000155.md) | [9.0 d](/filings/0001670076-26-000020.md) | [9.0](/filings/0001670076-26-000051.md) | [10.0](/filings/0001670076-25-000152.md) | [15.0](/filings/0001670076-25-000155.md) | [12.0 d](/filings/0001670076-26-000020.md) | [12.0](/filings/0001670076-26-000051.md) |
| Income tax | $m | [17.0](/filings/0001670076-24-000123.md) | [(13.0)](/filings/0001670076-24-000155.md) | [43.0 d](/filings/0001670076-26-000020.md) | [2.0](/filings/0001670076-25-000111.md) | [1.0](/filings/0001670076-25-000152.md) | [1.0](/filings/0001670076-25-000155.md) | [(3.0) d](/filings/0001670076-26-000020.md) | [3.0](/filings/0001670076-26-000051.md) | [0.0](/filings/0001670076-25-000152.md) | [1.0](/filings/0001670076-25-000155.md) | [(1.0) d](/filings/0001670076-26-000020.md) | [(9.0)](/filings/0001670076-26-000051.md) |
| Net income | $m | [71.0](/filings/0001670076-24-000155.md) | [(32.0)](/filings/0001670076-24-000155.md) | [(37.0) d](/filings/0001670076-26-000020.md) | [(26.0)](/filings/0001670076-25-000155.md) | [31.0](/filings/0001670076-25-000155.md) | [26.0](/filings/0001670076-25-000155.md) | [54.0 d](/filings/0001670076-26-000020.md) | [(43.0)](/filings/0001670076-26-000051.md) | [(70.0)](/filings/0001670076-25-000155.md) | [(77.0)](/filings/0001670076-25-000155.md) | [53.0 d](/filings/0001670076-26-000020.md) | [(272)](/filings/0001670076-26-000051.md) |
| Diluted EPS | $ per share | [0.31](/filings/0001670076-24-000123.md) | [(0.14)](/filings/0001670076-24-000155.md) | not reported | [(0.12)](/filings/0001670076-25-000111.md) | [0.14](/filings/0001670076-25-000152.md) | [0.11](/filings/0001670076-25-000155.md) | not reported | [(0.19)](/filings/0001670076-26-000051.md) | [(0.31)](/filings/0001670076-25-000152.md) | [(0.34)](/filings/0001670076-25-000155.md) | not reported | [(1.18)](/filings/0001670076-26-000051.md) |
| Basic EPS | $ per share | [0.32](/filings/0001670076-24-000123.md) | [(0.14)](/filings/0001670076-24-000155.md) | not reported | [(0.12)](/filings/0001670076-25-000111.md) | [0.14](/filings/0001670076-25-000152.md) | [0.11](/filings/0001670076-25-000155.md) | not reported | [(0.19)](/filings/0001670076-26-000051.md) | [(0.31)](/filings/0001670076-25-000152.md) | [(0.34)](/filings/0001670076-25-000155.md) | not reported | [(1.18)](/filings/0001670076-26-000051.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [780](/filings/0001670076-23-000071.md) | [640](/filings/0001670076-23-000086.md) | [609](/filings/0001670076-25-000041.md) | [622](/filings/0001670076-24-000079.md) | [658](/filings/0001670076-24-000123.md) | [576](/filings/0001670076-24-000155.md) | [740](/filings/0001670076-26-000020.md) | [686](/filings/0001670076-25-000111.md) | [563](/filings/0001670076-25-000152.md) | [566](/filings/0001670076-25-000155.md) | [671](/filings/0001670076-26-000051.md) | [772](/filings/0001670076-26-000051.md) |
| Current assets | $m | [1,009](/filings/0001670076-23-000071.md) | [936](/filings/0001670076-23-000086.md) | [871](/filings/0001670076-25-000041.md) | [903](/filings/0001670076-24-000079.md) | [947](/filings/0001670076-24-000123.md) | [910](/filings/0001670076-24-000155.md) | [990](/filings/0001670076-26-000020.md) | [953](/filings/0001670076-25-000111.md) | [832](/filings/0001670076-25-000152.md) | [847](/filings/0001670076-25-000155.md) | [958](/filings/0001670076-26-000051.md) | [1,098](/filings/0001670076-26-000051.md) |
| Total assets | $m | [4,708](/filings/0001670076-23-000071.md) | [4,935](/filings/0001670076-23-000086.md) | [4,993](/filings/0001670076-25-000041.md) | [5,206](/filings/0001670076-24-000079.md) | [5,689](/filings/0001670076-24-000123.md) | [5,826](/filings/0001670076-24-000155.md) | [6,153](/filings/0001670076-26-000020.md) | [6,481](/filings/0001670076-25-000111.md) | [6,524](/filings/0001670076-25-000152.md) | [6,701](/filings/0001670076-25-000155.md) | [7,220](/filings/0001670076-26-000051.md) | [7,017](/filings/0001670076-26-000051.md) |
| Current liabilities | $m | [1,645](/filings/0001670076-23-000071.md) | [1,689](/filings/0001670076-23-000086.md) | [1,658](/filings/0001670076-25-000041.md) | [1,797](/filings/0001670076-24-000079.md) | [1,821](/filings/0001670076-24-000123.md) | [1,724](/filings/0001670076-24-000155.md) | [1,852](/filings/0001670076-26-000020.md) | [1,942](/filings/0001670076-25-000111.md) | [2,045](/filings/0001670076-25-000152.md) | [2,110](/filings/0001670076-25-000155.md) | [2,103](/filings/0001670076-26-000051.md) | [2,238](/filings/0001670076-26-000051.md) |
| Total liabilities | $m | [4,142](/filings/0001670076-23-000071.md) | [4,394](/filings/0001670076-23-000086.md) | [4,486](/filings/0001670076-25-000041.md) | [4,722](/filings/0001670076-24-000079.md) | [5,169](/filings/0001670076-24-000123.md) | [5,277](/filings/0001670076-24-000155.md) | [5,549](/filings/0001670076-26-000020.md) | [5,911](/filings/0001670076-25-000111.md) | [6,018](/filings/0001670076-25-000152.md) | [6,267](/filings/0001670076-25-000155.md) | [6,729](/filings/0001670076-26-000051.md) | [6,795](/filings/0001670076-26-000051.md) |
| Long-term debt | $m | [193](/filings/0001670076-23-000071.md) | [220](/filings/0001670076-23-000086.md) | [219](/filings/0001670076-25-000041.md) | [201](/filings/0001670076-24-000079.md) | [189](/filings/0001670076-24-000123.md) | [279](/filings/0001670076-24-000155.md) | [241](/filings/0001670076-26-000020.md) | [244](/filings/0001670076-25-000111.md) | [234](/filings/0001670076-25-000152.md) | [305](/filings/0001670076-25-000155.md) | [313](/filings/0001670076-26-000051.md) | [343](/filings/0001670076-26-000051.md) |
| Current portion of debt | $m | [237](/filings/0001670076-23-000071.md) | [266](/filings/0001670076-23-000086.md) | [251](/filings/0001670076-25-000041.md) | [265](/filings/0001670076-24-000079.md) | [263](/filings/0001670076-24-000123.md) | [190](/filings/0001670076-24-000155.md) | [261](/filings/0001670076-26-000020.md) | [263](/filings/0001670076-25-000111.md) | [326](/filings/0001670076-25-000152.md) | [363](/filings/0001670076-25-000155.md) | [301](/filings/0001670076-26-000051.md) | [240](/filings/0001670076-26-000051.md) |
| Shareholders' equity | $m | [566](/filings/0001670076-24-000155.md) | [541](/filings/0001670076-24-000155.md) | [507](/filings/0001670076-26-000020.md) | [484](/filings/0001670076-25-000155.md) | [520](/filings/0001670076-25-000155.md) | [549](/filings/0001670076-25-000155.md) | [604](/filings/0001670076-26-000051.md) | [570](/filings/0001670076-26-000051.md) | [506](/filings/0001670076-25-000155.md) | [434](/filings/0001670076-25-000155.md) | [491](/filings/0001670076-26-000051.md) | [222](/filings/0001670076-26-000051.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(9.0) d](/filings/0001670076-24-000123.md) | [(173) d](/filings/0001670076-24-000155.md) | [(54.0) d](/filings/0001670076-26-000020.md) | [(22.0)](/filings/0001670076-25-000111.md) | [9.0 d](/filings/0001670076-25-000152.md) | [(156) d](/filings/0001670076-25-000155.md) | [87.0 d](/filings/0001670076-26-000020.md) | [(86.0)](/filings/0001670076-26-000051.md) | [(133) d](/filings/0001670076-25-000152.md) | [(215) d](/filings/0001670076-25-000155.md) | [(91.0) d](/filings/0001670076-26-000020.md) | [40.0](/filings/0001670076-26-000051.md) |
| Capital expenditure | $m | [12.0 d](/filings/0001670076-24-000123.md) | [14.0 d](/filings/0001670076-24-000155.md) | [14.0 d](/filings/0001670076-26-000020.md) | [17.0](/filings/0001670076-25-000111.md) | [31.0 d](/filings/0001670076-25-000152.md) | [14.0 d](/filings/0001670076-25-000155.md) | [14.0 d](/filings/0001670076-26-000020.md) | [18.0](/filings/0001670076-26-000051.md) | [33.0 d](/filings/0001670076-25-000152.md) | [2.0 d](/filings/0001670076-25-000155.md) | [22.0 d](/filings/0001670076-26-000020.md) | [12.0](/filings/0001670076-26-000051.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [219](/filings/0001670076-23-000071.md) | [220](/filings/0001670076-23-000086.md) | [218](/filings/0001670076-24-000079.md) | [220](/filings/0001670076-24-000123.md) | [221](/filings/0001670076-24-000155.md) | [223](/filings/0001670076-25-000111.md) | [227](/filings/0001670076-25-000152.md) | [226](/filings/0001670076-25-000155.md) | [227](/filings/0001670076-26-000051.md) | [228](/filings/0001670076-25-000152.md) | [228](/filings/0001670076-25-000155.md) | [229](/filings/0001670076-26-000051.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 229,789,335 at 2026-05-01, from the cover of the [10-Q filed 2026-05-05](/filings/0001670076-26-000051.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.